Stugeron
CAS No. 298-57-7
Stugeron( Cinnarizine | Stugeron | Dimitronal | Stutgin | Dimitron | Folcodal | Dihydrochloride Cinnarizine | Dimitronal )
Catalog No. M13913 CAS No. 298-57-7
Cinnarizine is a drug derivative of piperazine, and characterized as an antihistamine and a calcium channel blocker.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product NameStugeron
-
NoteResearch use only, not for human use.
-
Brief DescriptionCinnarizine is a drug derivative of piperazine, and characterized as an antihistamine and a calcium channel blocker.
-
DescriptionCinnarizine is a drug derivative of piperazine, and characterized as an antihistamine and a calcium channel blocker, it is also known to promote cerebral blood flow, and so is used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis.
-
In Vitro——
-
In Vivo——
-
SynonymsCinnarizine | Stugeron | Dimitronal | Stutgin | Dimitron | Folcodal | Dihydrochloride Cinnarizine | Dimitronal
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel| H1 receptor
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number298-57-7
-
Formula Weight368.51
-
Molecular FormulaC26H28N2
-
Purity>98% (HPLC)
-
SolubilitySoluble in DMSO
-
SMILESC1CN(CCN1C/C=C/C2=CC=CC=C2)C(C3=CC=CC=C3)C4=CC=CC=C4
-
Chemical Name1-benzhydryl-4-[(E)-3-phenylprop-2-enyl]piperazine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Terland O, et al. Neuropharmacology. 1999 Jun;38(6):879-82.
molnova catalog
related products
-
OPC 8490 free base
OPC 8490 free base is a novel positive inotropic vasodilator and a cardiotonic agent that increases Ca currents in a dose-dependent and reversible manner and can be used to study cardiovascular diseases.
-
TTA-Q6
TTA-Q6, a selective T-type Ca2+ channel antagonist, exhibits potential antitumor and immunomodulatory activities for treating neurological disorders by inhibiting the uptake of extracellular calcium ions by tumor cells, thereby inducing intracellular calcium deficiency and endoplasmic reticulum (ER) stress.
-
Gallopamil
Gallopamil inhibits acid secretion in a concentration-dependent manner with an IC50 of 10.9 μM.
Cart
sales@molnova.com